ADVANTAGES OF USING LIPOSOME-ENCAPSULATED ANTIBIOTICS TO FIGHT INFECTIONS CAUSED BY ENTEROBACTERIA. Journal of Population Therapeutics and Clinical Pharmacology, [S. l.], v. 31, n. 9, p. 731–740, 2024. DOI: 10.53555/nhwgvd87. Disponível em: https://jptcp.com/index.php/jptcp/article/view/7835. Acesso em: 28 sep. 2024.